The Impact of Right to Try Laws on Medical Access in the United States

Simple item page
dc.contributor.authorRubin, Michelle J.en_US
dc.contributor.authorMatthews, Kirstin R.W.en_US
dc.contributor.orgJames A. Baker III Institute for Public Policyen_US
dc.date.accessioned2016-06-10T16:13:24Zen_US
dc.date.available2016-06-10T16:13:24Zen_US
dc.date.issued2016-05en_US
dc.description.abstractState "right to try" laws can give terminally ill patients early access experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.en_US
dc.identifier.citationRubin, Michelle J. and Matthews, Kirstin R.W.. "The Impact of Right to Try Laws on Medical Access in the United States." 66, (2016) James A. Baker III Institute for Public Policy: <a href="http://bakerinstitute.org/research/right-try-unproven-drugs/">http://bakerinstitute.org/research/right-try-unproven-drugs/</a>.en_US
dc.identifier.urihttps://hdl.handle.net/1911/90473en_US
dc.publisherJames A. Baker III Institute for Public Policyen_US
dc.titleThe Impact of Right to Try Laws on Medical Access in the United Statesen_US
dc.typeReporten_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
CHB-pub-PolicyReport66.pdf
Size:
592.17 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Baker Institute Publications